1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-R-04, NCT00058474, CALGB-NSABP-R-04
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ACOSOG-Z6051, Z6051, NCT00726622
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-345, NCT00307736
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0080, NCT00543842
|
|
5.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCIRVINE-UCI06-8-01, UCI06-8-01, NCT00754494
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3304C, NCT00250835
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCSF-03451, UCSF-H44287-23127-03, NCT00335816, UMN-2003UC036
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E3204, E3204, NCT00321685
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 803437, UPCC 09204, NCT00353457
|
|
10.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: CINJ-3330, NCT00161187
|
|
11.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ETH190-06, ETH190-06, NCT00601198
|
|
12.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: RPCI-I-113607, I 113607, NCT00625183
|
|
13.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0713, S0713, NCT00686166
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0644, NCT00745134
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BIMCP-OX-08-006, OX-08-006, AVENTIS-BIMCP-OX-08-006, NCT00831181
|
|
16.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: CCUM-TASK2B, LRI-6930, N01-CN-25025-4, NCT00433576
|
|
17.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: No. 200509024, NCT00336609
|
|
18.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J-06109, NCT00414232
|
|
19.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2003-0962, NCT00415675
|
|
20.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-07021, 07-021, NCT00462501
|
|
21.
|
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 10-06-33, NCT00487409
|
|
22.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UNC-LCCC-0216, LCCC 0216, NCT00280761
|
|
23.
|
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 06-082, R03 CA119756-01, NCT00578838
|
|
24.
|
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 03-127, NCT00597610
|
|
25.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 07-049, NCT00693173
|
